What is the role for idelalisib and duvelisib in CLL?
Changing epigenetic markers in CLL patients on ibrutinib
The importance of PI3-kinase delta in CLL and NHL
An update on kinase inhibitors from EHA 2017
The 20th anniversary of the German CLL Study Group and the importance of collaboration